Performance Anxiety

Neurology
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

VP
Vanda PharmaceuticalsWASHINGTON, DC
1 program
1
VQW-765Phase 21 trial
Active Trials
NCT04800237Completed230Est. Aug 2022
T-Therapeutics
T-TherapeuticsUK - Cambridge
1 program
Virtual Reality PsychotherapyN/A1 trial
Active Trials
NCT06639841Active Not RecruitingEst. Jul 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Vanda PharmaceuticalsVQW-765
T-TherapeuticsVirtual Reality Psychotherapy

Clinical Trials (2)

Total enrollment: 230 patients across 2 trials

Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety

Start: Feb 2021Est. completion: Aug 2022230 patients
Phase 2Completed
NCT06639841T-TherapeuticsVirtual Reality Psychotherapy

Effectiveness of Virtual Reality Psychotherapy and Yoga on Student Performance Anxiety

Start: Sep 2024Est. completion: Jul 2025
N/AActive Not Recruiting

Related Jobs in Neurology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space